Rikoon Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$941K Buy
4,293
+763
+22% +$153K 0.25% 93
2020
Q4
$617K Buy
3,530
+873
+33% +$151K 0.17% 120
2020
Q3
$430K Hold
2,657
0.13% 134
2020
Q2
$379K Hold
2,657
0.13% 140
2020
Q1
$289K Buy
2,657
+1,207
+83% +$174K 0.12% 143
2019
Q4
$211K Hold
1,450
0.07% 195
2019
Q3
$209K Hold
1,450
0.08% 195
2019
Q2
$215K Buy
+1,450
New +$202K 0.08% 193

Other funds holding LH

Rikoon Group's LH Position: Q1 2021 in Review

Rikoon Group increased its Labcorp (LH) stake by 22% in Q1 2021, buying an estimated $153K and bringing the position to 4,293 shares worth $941K. The position accounts for 0.25% of the portfolio, ranked #93.

Rikoon Group first reported a position in LH in Q2 2019 and has held it in 8 quarters since. 921 funds tracked by Wall St. Rank hold LH as of Q1 2021.

  • Rikoon Group held 4,293 shares of Labcorp worth $941K as of Q1 2021.
  • Rikoon Group bought 763 Labcorp shares in Q1 2021, an estimated $153K.
  • Labcorp made up 0.25% of Rikoon Group's portfolio in Q1 2021, its #93 holding.
  • Rikoon Group first reported a position in Labcorp in Q2 2019 and has held it in 8 quarters since.
  • 921 funds tracked by Wall St. Rank held Labcorp as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.